Terapevticheskii arkhivTerapevticheskii arkhiv0040-36602309-5342LLC Obyedinennaya Redaktsiya3298410.26442/terarkh201890915-26Research ArticleFeatures of the clinical picture in patients of middle age with essential hypertensionParfenovV AVladimirparfenov@mail.ruOstroumovaT MT.ostroumova3@gmail.comOstroumovaO Dostroumova.olga@mail.ruPavleyvaE Epavleeva.elena@mail.ruFederal State Autonomous Educational Institution of the higher eduction Sechenov First Moscow State Medical University. (Sechenov University) of the Ministry of Health of RussiaFederal State Autonomous Educational Institution of the higher eduction Evdokimov Moscow State Medical-Stomatological University of the Ministry of Health of Russia15092018909152611042020Copyright © 2018, Consilium Medicum2018Aim. To evaluate the presence and the severity of the complaints (headache, dizziness, memory loss, concentration of attention, sleep disturbances, decreased mood, increased anxiety), the state of cognitive functions, emotional status and quality of night sleep in treatment-naïve middle-aged patients with mild to moderate EAH compared to healthy volunteers of the same age. Materials and methods. 103 treatment-naïve patients with EAH aged 40-59 years at the enrollment, who met the inclusion/exclusion criteria and provided written informed consent (46 men, mean age 53.6±0.8 years) and 50 healthy volunteers (17 men, mean age 51.5±1.0 years) with normal blood pressure (BP) level - control group - were enrolled to the study. Mean EAH duration was 2.9±5.7 years. Cognitive assessment included Montreal cognitive assessment, 10-words learning task, verbal fluency test, TMT, Stroop color and word test. Anxiety and depression were evaluated via Hamilton rating scales (HARS and HDRS). 24-hours ambulatory BP monitoring (ABPM) was performed according to European guidelines. Results. 70% of patients with EAH complained of memory disturbance, 68% - lack of attention, 22% - sleep disturbances, 12% - dizziness, 9% - headache. It took statistically significant more time for patients with EAH to perform on TMT B (p<0.05), they had significantly higher TMT B - TMT A difference score (p<0.01) and lower mean MoCA score (p<0.05). Patients with EAH had significantly higher mean score in Hamilton anxiety (2.1±3.7) and depression (1.1±2.4) rating scales compared to controls (0.3±0.9 points, p<0.01 and 0.1±0.5 points, p<0.001, respectively). Patients with EAH who complained of sleep disturbances had low sleep quality (8.7±2.8 points). Among patients with EAH who complained about headaches 66.6% had episodic migraine and chronic tension type headache (33.4%). Those patients had a substantial impact of headache on life and daily living according to HIT-6 (mean score - 57.5±6.1). Only 2 patients out of 12 with complains about dizziness had benign paroxysmal positional vertigo and Ménière's disease. Conclusion. Complaints about memory dysfunction, lack of attention, sleep disturbances, less common - dizziness and headaches, are most typical in patients with EAH on the early stages of the disease. They differ from healthy volunteers of the same age by having cognitive impairment and higher anxiety and depression scores. Patients with EAH who complained about sleep disturbances had low sleep quality. Headache in patients with EAH was due to episodic migraine and tension type headache which had a negative impact on life and daily living.essential arterial hypertensionmiddle agecognitive functionssleep disturbancesheadachedizzinessanxietydepressionартериальная гипертензиясредний возрасткогнитивные функциинарушения снаголовная больголовокружениетревогадепрессия[Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee D.E, Jaarsma T, Kirchhof P, Kjeldsen S.E, Laurent S, Manolis A.J, Nilsson P.M, Ruilope L.M, Schmieder R.E, Sirnes P, Sleight P, Viigimaa M, Waeber B, Zannad F. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Hypertens J. 2013;31:1281-357. doi:10.1093/eurheartj/eht151][Чазова И.Е., Ратова Л.Г., Бойцов С.А., Небиеридзе Д.В. Диагностика и лечение артериальной гипертензии. (Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов). Системные гипертензии. 2010;3:5-26][Бойцов С.А., Баланова Ю.А., Шальнова С.А., Деев А.Д., Артамонова Г.В., Гатагонова Т.М., Дупляков Д.В., Ефанов А.Ю., Жернакова Ю.В., Конради А.О., Либис Р.А., Минаков А.В., Недогода С.В., Ощепкова Е.В., Романчук С.А., Ротарь О.П., Трубачева И.А. И.А., Чазова И.Е., Шляхто Е.В., Муромцева Г.А., Евстифеева С.Е., Капустина А.В., Константинов В.В., Оганов Р.Г., Мамедов М.Н., Баранова Е.И., Назарова О.А., Шутемова О.А., Фурменко Г.И., Бабенко Н.И., Азарин О.Г., Бондарцов Л.В., Хвостикова А.Е., Ледяева А.А., Чумачек Е.В., Исаева Е.Н., Басырова И.Р., Кондратенко В.Ю., Лопина Е.А., Сафонова Д.В., Скрипченко А.Е., Индукаева Е.В., Черкасс Н.В., Максимов С.А., Данильченко Я.В., Мулерова Т.А., Шалаев С.В., Медведева И.В., Шава В.П., Сторожок М.А., Толпаров Г.В., Астахова З.Т., Тогузова З.А., Кавешников В.С., Карпов Р.С., Серебрякова В.Н. Артериальная гипертония среди лиц 25-64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования эссе. Кардиоваскулярная терапия и профилактика. 2014;13(4):4-14 doi:10.15829/1728-8800-2014-4-4-14][Beckett N.S, Peters R, Fletcher A.E, Staessen J.A, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen R.L, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt C.J. HYVET Study Group Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887-98. doi: 10.1056/NEJMoa0801369][The ALLHAT officers and coordinators for the ALLHAT collaborative research group. Major outcome in high - risk hypertensive patients randomized to angiotensin - converting enzyme inhibitor or calcium channel blоcker vs diuretic. The antihypertensive and lipid - lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288:2981-97. doi:10.1001/jama.288.23.2981][Systolic Hypertension in the Elderly Program Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program. JAMA. 1991;265:3255-64. doi:10.1001/jama.1991.03460240051027][Staessen J.A, Fagard R, Thijs L, Celis H, Birkenhäger W.H, Bulpitt C.J, de Leeuw P.W, Fletcher A.E, Babarskiene M.R, Forette F, Kocemba J, Laks T, Leonetti G, Nachev C, Petrie J.C, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Zanchetti A. Subgroup and per - protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. Arch Intern Med. 1998;158(15):1681-91. PMID: 9701103][Blood Pressure Lowering Treatment Trialists' Collaboration. Blood pressure - lowering treatment based on cardiovascular risk: a meta - analysis of individual patient data. Lancet. 2014;384(9943):591-8. doi: 10.1016/S0140-6736(14)61212-5][Ettehad D, Emdin C.A, Kiran A, Anderson S.G, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta - analysis. Lancet. 2016;387(10022):957-67. doi: 10.1016/S0140-6736(15)01225-8][Конради А.О., Полуничева Е.В. Недостаточная приверженность к лечению артериальной гипертензии: причины и пути коррекции. Артериальная гипертензия. 2004;3:137-43][Simpson S.H, Eurich D.T, Majumdar S.R, Padwal R.S, Tsuyuki R.T, Varney J, Johnson J.A. A meta - analysis of the association between adherence to druq therapy and mortality. Br Med J. 2006;333(7557):15-20. doi:10.1136/bmj.38875.675486.55][Парфенов В.А., Алексеев В.В., Шварева Н.С., Рыжак А.А. Головная боль у больных артериальной гипертонией. Клиническая геронтология. 2001;6(5):3-9][Парфенов В.А., Неверовский Д.В. Ведение пациентов с дисциркуляторной энцефалопатией в амбулаторной практике. Неврология, нейропсихиатрия, психосоматика. 2015;7(1):37-42 [doi: http://dx.doi.org/10.14412/2074-2711-2015-1-37-42][Парфенов В.А., Замерград М.В., Мельников О.А. Головокружение: диагностика и лечение, распространенные диагностические ошибки. М.: МИА, 2009. 152 с.][Толмачева В.А., Парфенов В.А. Причины головокружения у пациентов с артериальной гипертензией и его лечение. Врач. 2007;(4):49-53][Nasreddine Z.S, Phillips N.A, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings J.L, Chertkow H. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-9. doi:10.1111/j.1532-5415.2005. 53221.x][Nasreddine Z. MoCA Russian version, 2010. Available from: http://www.mocatest.org/wp-content/uploads/2015/tests-instructions/MoCA-Test-Russian_2010.pdf][Morris J.C, Heyman A, Mohs R.C, Hughes J.P, Belle G van, Fillenbaum G. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology. 1989;39:1159-65.][Парфенов В.А., Захаров В.В., Преображенская И.С. Когнитивные расстройства. М., 2014; 192 с.][Reitan R. validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271-6.][Mac Leod C.M. Half a century of research on the Stroop effect: An integrative review. Psychol Bull. 1991;109(2):163-203.][Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-5.][Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.][Bayliss M, Batenhorst A. The HIT-6™: a user's guide. USA: QualityMetric, Inc: Lincoln, RI, 2002.][Kerns R.D, Turk D.C, Rudy T.E. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain. 1985;23:345-56.][Buysse D.J, Reynolds III C.F, Monk T.H, Berman S.R, Kupfer D.J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Research. 1989;28:193-213.][O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head G.A, Imai Y, Kario K, Lurbe E, Mallion J-M, Mancia G, Mengden Th, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope L.M, Shennan A, Staessen J.A, van Montfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y. On behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. Guidelines European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring. J Hypertension. 2013;31:1731-68. doi: 10.1097/HJH.0b013e328363e964][Парфенов В.А., Старчина Ю.А. Когнитивные нарушения у пациентов с артериальной гипертензией и их лечение. Неврология, нейропсихиатрия, психосоматика. 2011;3(1):27-33 doi:10.14412/2074-2711-2011-130][Старчина Ю.А., Парфенов В.А., Чазова И.Е. и др. Когнитивные расстройства у пациентов с артериальной гипертензией. Журнал неврол и психиатр им. С.С. Корсакова. 2008;4:39-43][Diagnostic and statistical manual of mental diseases. V ed. (DSM-V). London: American Psychiatric Association, 2013. 947 p.][van Boxtel M.P.J, Henskens L.H.G, Kroon A.A, et al. Ambulatory blood pressure, asymptomatic cerebrovascular damage and cognitive function in essential hypertension. J Hum hypertension. 2006;20(1):5-13. doi: 10.4061/2011/478710][Захаров В.В. Когнитивные расстройства без деменции: классификация, основные причины и лечение. Эффективная фармакотерапия. Неврология. 2016;1:22-][Frank J, Rebecca E.A, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis K.A, van der Flier W.M, Glodzik L, van Harten A.C, de Leon M.J, Mc Hugh P, Mielke M.M, Molinuevo J.L, Mosconi L, Osorio R.S, Perrotin A, Petersen R.C, Rabin L.A, Rami L, Reisberg B, Rentz D.M, Sachdev P.S, de la Sayette V, Saykin AJ, Scheltens P, Shulman M.B, Slavin M.J, Sperling R.A, Stewart R, Uspenskaya O, Vellas B, Visser P.J, Wagner M, and Subjective Cognitive Decline Initiative (SCD-I) Working Group. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimer’s Dement. 2014;10(6):844-52. doi:10.1016/j. jalz.2014. 01.001][Остроумова О.Д., Галеева Н.Ю. Новые тенденции в лечении артериальной гипертонии 2013 года: ренессанс пульсового АД. Системные гипертензии. 2014;11(1):52-6][Chenniappan M. Blood Pressure Variability: Assessment, Prognostic Significance and Management. J The Association of Physicians of India. 2015;63:47-53.][Kanemary A, Kanemary K, Kuwajima I. The effects of Short-Term blood pressure variability and nighttime blood pressure levels on cognitive function. Hypertens Res. 2001;24:19-24. doi: https://doi.org/10. 1291/hypres.24.19][Sakakura K, Ishikawa J, Okuno M, Shimada K, Kario K. Exaggerated Ambulatory Blood Pressure Variability Is Associated with Cognitive Dysfunction in the Very Elderly and Quality of Life in the Younger Elderly. AJH. 2007;20:720-7. doi: https://doi.org/10.1016/j. amjhyper.2007.02.001][Leoncini G, Viazzi F, Storace G, Deferrari G, Pontremoli R. Blood pressure variability and multiple organ damage in primary hypertension. J Hum Hypertens. 2013;27(11):663-70. doi: 10.1038/jhh.2013.45][Headache Classification Committee of the International Headache Society (IHS).The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2013;33(9):629-808. doi: 10.1177/ 0333102413485658][Russmussen B.K, Jensen R, Shroll M, Olsen J. Epidemiology of a general population - a prevalence study. J Clin Epidemiol.1991;44(11): 1147-57. doi: https://doi.org/10.1016/0895-4356(91)90147-2][Lyngberg A.C, Rasmussen B.K, Jшrgensen T, Jensen R. Incidence of Primary Headache: A Danish Epidemiologic Follow - up Study. Am J Epidemiol. 2005;161:1066-73. doi: 10.1093/aje/kwi139][Victor T.W, Hu X, Campbell J.C, Buse D.C, Lipton R.B. Migraine prevalence by age and sex in the United States: A life - span study. Cephalalgia. 2010;30:1065. doi: 10.1177/0333102409355601][Толмачева В.А. Причины головокружения. Неврология, нейропсихиатрия, психосоматика. 2010;2(4):18-23. doi: http://dx.doi.org/10.14412/2074-2711-2010-111.][Миронов С.П., Щепин О.П., Романов А.И., Максимова Т.М. Концептуальная и экспериментальная проработка эпидемиологии нарушений сна у населения России. Кремлевская медицина. Клинический вестник. 1998;5:17-23][Верткин А.Л., Алексанян Л.А., Любшина О.В., Манченко Н.В., Вигант М.С. Зависимость нарушений сна от уровня артериального давления у пациентов с гипертонической болезнью. Медицинская кафедра. 2003;4(8):142-9][Ольбинская Л.И., Хапаев Б.А. Нарушения сна у больных с артериальной гипертензией - возможный фактор риска и предиктор сердечно - сосудистых и цереброваскулярных осложнений. Кардиология. 1999;6:18-22]